GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (FRA:AEQ) » Definitions » Pretax Margin %

Aequus Pharmaceuticals (FRA:AEQ) Pretax Margin % : -417.35% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Aequus Pharmaceuticals Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Aequus Pharmaceuticals's Pre-Tax Income for the three months ended in Sep. 2024 was €-0.41 Mil. Aequus Pharmaceuticals's Revenue for the three months ended in Sep. 2024 was €0.10 Mil. Therefore, Aequus Pharmaceuticals's pretax margin for the quarter that ended in Sep. 2024 was -417.35%.

The historical rank and industry rank for Aequus Pharmaceuticals's Pretax Margin % or its related term are showing as below:

FRA:AEQ' s Pretax Margin % Range Over the Past 10 Years
Min: -1162.75   Med: -215.74   Max: -40.3
Current: -647.94


FRA:AEQ's Pretax Margin % is ranked worse than
94.94% of 988 companies
in the Drug Manufacturers industry
Industry Median: 5.38 vs FRA:AEQ: -647.94

Aequus Pharmaceuticals Pretax Margin % Historical Data

The historical data trend for Aequus Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aequus Pharmaceuticals Pretax Margin % Chart

Aequus Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -190.23 -40.32 -66.65 -232.64 -1,164.94

Aequus Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6,188.89 -1,397.14 -1,250.00 -424.77 -417.35

Competitive Comparison of Aequus Pharmaceuticals's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Aequus Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aequus Pharmaceuticals's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aequus Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Aequus Pharmaceuticals's Pretax Margin % falls into.



Aequus Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Aequus Pharmaceuticals's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-2.027/0.174
=-1,164.94 %

Aequus Pharmaceuticals's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-0.409/0.098
=-417.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aequus Pharmaceuticals  (FRA:AEQ) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Aequus Pharmaceuticals Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Aequus Pharmaceuticals's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aequus Pharmaceuticals Business Description

Traded in Other Exchanges
Address
200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.

Aequus Pharmaceuticals Headlines

No Headlines